PDSB Earnings

Quarterly EPS
$-0.29
Q3 2024
$-0.21
Q4 2024
$-0.21
Q1 2025
$-0.21
Q2 2025
$-0.19
Q3 2025
$-0.14
Q4 2025
$-0.13
Q1 2026
$-0.18
Q2 2026
Latest RevenueN/A
Latest Net Income-9750575
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.180-9750575—+14.3%
Q1 2026-$0.130-7349056—+38.1%
Q4 2025-$0.140-7562919—+33.3%
Q3 2025-$0.190-9009411—+34.5%
Q2 2025-$0.210-9434208—+8.7%
Q1 2025-$0.210-8488967—+30.0%
Q4 2024-$0.210-7952352—+38.2%
Q3 2024-$0.290-10726658—+17.1%
Q2 2024-$0.230-8327897——
Q1 2024-$0.300-10603477——
Q4 2023-$0.340-10898216——
Q3 2023-$0.350-10849169——
PDS Biotechnology (PDSB) — Earnings